ISIN | LU2488092722 |
---|---|
Valor Number | 119403767 |
Bloomberg Global ID | |
Fund Name | Kieger Sustainable Healthcare Fund Class B CHF Accumulating |
Fund Provider |
Kieger AG
Kieger AG Limmatstrasse 264, CH-8005 Zürich Phone: +41 44 444 18 44 Web: https://kieger.com/ E-Mail: info@kieger.com |
Fund Provider | Kieger AG |
Representative in Switzerland |
ACOLIN Fund Services AG Zürich Phone: +41 44 396 96 96 |
Distributor(s) | |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The investment objective of the Sub-Fund is to achieve long term capital growth by principally investing in equities of healthcare and healthcare related issuers worldwide (including Emerging Markets). The Sub-Fund aims to have a positive impact on society by investing in sustainable companies with current or future activities positively contributing to good health and well-being. The objective is reached by investing in innovative companies with differentiated products and/or services that are leaders in sustainability as identified through a proprietary sustainability framework developed by the Investment Manager. |
Peculiarities |
Current Price * | 96.39 CHF | 18.08.2025 |
---|---|---|
Previous Price * | 94.76 CHF | 14.08.2025 |
52 Week High * | 117.58 CHF | 02.09.2024 |
52 Week Low * | 91.74 CHF | 07.08.2025 |
NAV * | 96.39 CHF | 18.08.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 173,214,118 | |
Unit/Share Assets *** | 803,592 | |
Trading Information SIX |
YTD Performance | -11.14% |
31.12.2024 - 18.08.2025
31.12.2024 18.08.2025 |
---|---|---|
1 month | +2.26% |
18.07.2025 - 18.08.2025
18.07.2025 18.08.2025 |
3 months | -3.68% |
19.05.2025 - 18.08.2025
19.05.2025 18.08.2025 |
6 months | -15.95% |
18.02.2025 - 18.08.2025
18.02.2025 18.08.2025 |
1 year | -17.38% |
19.08.2024 - 18.08.2025
19.08.2024 18.08.2025 |
2 years | -3.15% |
18.08.2023 - 18.08.2025
18.08.2023 18.08.2025 |
3 years | -3.61% |
20.03.2023 - 18.08.2025
20.03.2023 18.08.2025 |
5 years | - | - |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Abbott Laboratories | 5.91% | |
---|---|---|
Eli Lilly and Co | 5.61% | |
AstraZeneca PLC | 5.57% | |
Novartis AG Registered Shares | 5.48% | |
Roche Holding AG | 4.86% | |
Vertex Pharmaceuticals Inc | 4.12% | |
Boston Scientific Corp | 3.96% | |
Intuitive Surgical Inc | 3.76% | |
Novo Nordisk AS Class B | 3.63% | |
UnitedHealth Group Inc | 3.47% | |
Last data update | 31.05.2025 |
TER *** | 0.99% |
---|---|
TER date *** | 30.09.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.85% |
Ongoing Charges *** | 0.99% |
SRRI ***
|
|
SRRI date *** | 31.07.2025 |